Aprea Therapeutics Inc (APRE) Directors and Executive Officers

Officers & Directors

Bernd R. Seizinger
Director

Jean-Pierre Bizzari
Director

Oren Gilad, Ph.D.
President and Chief Executive Officer

John P. Hamill
Chief Financial Officer (Principal Financial and Accounting Officer)

John B. Henneman, III
Director

Rifat Pamukcu
Director

Marc Duey
Director

Richard Peters
Director

Michael Grissinger
Director

Gabriela Gruia
Director ,

Aprea Therapeutics Inc currently has 8 employees.

News about Aprea Therapeutics Inc Key Personnel

Aprea Therapeutics Announces Engagement of Dr. Philippe Pultar as Senior Medical Advisor to Lead Development of WEE1 Inhibitor APR-1051 Amid New Clinical Trial Initiatives,

Aprea Therapeutics Expands Expertise with Appointment of Philippe Pultar, MD, to Lead WEE1 Clinical Development Amid New Trial InitiativesAprea Therapeutics Inc. a clinical-stage biopharmaceutical company specializing in precision oncology through the innovative concept of synthetic lethality, has made significant strides in its quest to advance cancer treatment options. On October 9, 2024, the company announced the engagement of Dr. Philippe Pultar as its Senior Medical Advisor, a strategic decision aimed at enhancing the development and clinical advancement of its promising WEE1 inhibitor, APR-1051. Strengthening Leadership in Clinical DevelopmentDr. Pultar brings a wealth of experience to Aprea Therapeuti...